Board of Directors

Danny Yeung is the Co-Founder of Prenetics and has served as Chief Executive Officer since its inception in 2014. Mr. Yeung’s journey into healthcare started as a way to utilize his extensive entrepreneurial career into making an impact for society. Mr. Yeung’s vision from day 1 was to always turn Prenetics into a global health company, recruiting the best talent, and to give everyone the power to be in control of their own health.

Prior to Prenetics, Mr. Yeung was a Founding Partner at SXE Ventures, having led multiple investments in genetic testing companies and in Honey Science, which was acquired by Paypal for US $4 billion in 2019. Mr. Yeung had also founded uBuyiBuy in 2010, which was subsequently acquired by Groupon. Prior to leaving Groupon in early 2014, Mr. Yeung served as CEO of Groupon East Asia, leading it to be the largest e-commerce company in the region. Mr. Yeung’s entrepreneurial journey started at the age of 25 when he ventured into franchising Hong Kong dessert chain “Hui Lau Shan” into the USA. After exiting Hui Lau Shan, Mr. Yeung successfully ventured into hospitality furniture and executed multi-million-dollar projects with MGM globally. Mr. Yeung’s life motto is “Play Hard, Work Harder”.

Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both private and public companies. From 2022 until recently, he was CEO of Nirvana Water Sciences, where he developed a team of industry beverage, functional beverage, and supplement experts to transform the brand, product portfolio, go-to-market strategy, and execution of the business.

From 2002 to 2015, Mr. Vanderveen was the founder and CEO of XS Worldwide, a company with a portfolio of energy drinks and sports nutrition products. XS partnered with Amway Corporation and became the fastest-growing business segment and category for the world’s largest direct seller, reaching annual sales over $400 million with distribution in more than 60 countries. XS was sold to Amway in 2015, where Mr. Vanderveen served as Vice President and Global General Manager for the XS brand, achieving maximum earn-out through 2018.

Mr. Vanderveen is also an advisor and limited partner at RX3 Growth Partners, a private equity firm that partners with consumer brands and other leading investment firms to maximize value by leveraging its unique influencer base of athletes, celebrities, and thought leaders, and is a general partner in LLB Global Fund, an international arbitration fund in partnership with French law firm, Lazareff Le Bars.

Mr. Ben Cheng has been proposed as an Executive Board Member and CEO of C Capital AG. He serves as the President and CEO of C Capital, a global asset management platform specializing in private equity, private credit fund and blockchain hedge fund strategies. Under his leadership, C Capital has made significant strides in the investment landscape, focusing on transformative opportunities across various sector.

With extensive experience in venture capital and private equity, Mr. Cheng has played a pivotal role in high-profile investments, including CASETiFY, the fastest-growing global tech accessories brand; XiaoPeng (NYSE: XPEV), a leading Chinese electric vehicle manufacturer; Animoca Brands, a multinational blockchain technology; NOTHING, a UK-based consumer electronics manufacturer; Lalamove, a prominent Chinese on-demand logistics firm. He is also a board member of Prenetics Global Limited (Nasdaq: PRE) and holds a Non-executive Director position at Ocean Line Port Development Limited (8502.HK).

In addition to his operational roles, Mr. Cheng actively contributes to the community as a committee member of Hong Kong Trade Development Council Mainland Business Advisory Committee and the Venture Committee of Hong Kong Venture Capital and Private Equity Association. He is also a committee member of The LRC Charitable Foundation (LRCCF).

Prior to C Capital, Mr. Cheng honed his expertise as an investment banker at Bank of America Merrill Lynch and Standard Chartered Bank, where he was involved in landmark transactions such as the US$3.3 billion take-private of WuXi PharmaTech, Temasek’s US$5.7 billion investment in Watson’s and the US$2.1 billion acquisition of ING's insurance business in Hong Kong, Macau and Thailand.

Mr. Cheng’s diverse experience and strategic vision position him as a key leader in the investment community, driving innovation and growth at C Capital and beyond.

Mr. Cheung brings extensive leadership experience in digital asset operations and financial technology to Prenetics' Board. He previously served as Chief Operating Officer of OKEx, one of the world's largest cryptocurrency exchanges, where he managed global operations for a platform handling billions of dollars in daily trading volume. Mr. Cheung currently serves as Co-Founder and Chief Executive Officer of OEX, a digital asset trading platform, and Co-Founder and Chief Executive Officer of PredicXion, a blockchain-based and AI-Powered prediction market. Mr. Cheung and Prenetics CEO Danny Yeung previously collaborated at Groupon approximately 15 years ago, establishing a proven working relationship and mutual trust that enhances board effectiveness. His appointment strengthens Prenetics' strategic capabilities as the Company executes on its Bitcoin treasury strategies and digital asset initiatives.